A new Blood Advances study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face an increased risk of developing venous thromboembolism (VTE), or blood clots in the veins, three months ...
Apr 13, 2022
0
9
A study from Sweden published by The BMJ today finds an increased risk of deep vein thrombosis (a blood clot in the leg) up to three months after COVID-19 infection, pulmonary embolism (a blood clot in the lung) up to six ...
Apr 6, 2022
0
21
A Kaiser Permanente analysis of pregnant patients who tested positive for the coronavirus found more than double the risk of poor outcomes including preterm birth, venous thromboembolism (blood clot), and severe maternal ...
Mar 21, 2022
0
5
(HealthDay)—Comprehensive clinic-based care may be acceptable for carefully selected adults diagnosed with acute pulmonary embolism in the primary care setting, according to a study published online Jan. 12 in the Journal ...
Jan 25, 2022
0
0
(HealthDay)—For patients with psoriasis, the risk for cancer is increased at the time of or after venous thromboembolism (VTE), according to a research letter published online Jan. 18 in the British Journal of Dermatology.
Jan 24, 2022
0
26
For patients at high risk for venous thromboembolism (VTE) discharged after COVID-19 hospitalization, thromboprophylaxis with rivaroxaban is associated with improved clinical outcomes, according to a study published online ...
Dec 30, 2021
0
12
(HealthDay)—For patients hospitalized with COVID-19, risk factors for postdischarge venous thromboembolism (VTE) include history of VTE, peak D-dimer level greater than 3 µg/mL, and predischarge C-reactive protein level ...
Dec 8, 2021
0
3
(HealthDay)—There is an increased risk for venous thromboembolism (VTE) and peripheral vascular disease (PVD) among patients with psoriatic disease, according to a review published online Dec. 1 in JAMA Dermatology.
Dec 8, 2021
0
0
(HealthDay)—For people suffering from clots in their legs, a new study finds that one of two commonly used blood thinners is safer and more effective than the other.
Dec 7, 2021
0
5
No aspect of SARS-CoV-2 infection has been more startling—or problematic—than the elevated risk for blood clotting, a concern that throughout the pandemic has been associated with severe COVID-19, frequently characterized ...
